a first-in-class HIF-2α inhibitor. The findings are published in The Lancet Oncology journal. The researchers previously reported results for cohort 2 of the trial, which includes patients ...

HIF Global, the leader in highly innovative fuels, is proud to announce that it has been awarded the first U.S. approval for an e-Fuels pathway. The Tier II Design Pathway Certification, granted under ...